WHEN I FIRST TRIED psychedelics in the 1970s, I wasn’t trying to heal myself. I was curious to find out how psychedelics, including LSD and “magic” mushrooms, could alter my consciousness.
My trip into hallucinogenic world of psychedelics wasn’t as studious as Aldous Huxley’s. He took notes as he journeyed into a state of altered perception. In his book, The Doors of Perception, he says:
“Half an hour after swallowing the drug I became aware of a slow dance of golden lights . . .”
That’s pretty much the way my experience went. It wasn’t always a joy ride – not something you tried casually. It required commitment and was truly a “trip.” Once you stepped onto that path, more like a conveyor belt, there was no turning back at for many hours.
“Turn on, tune in, drop out” was a phrase first popularized by Timothy Leary in 1966. He was a promoter of psychedelics as part of the hippy counterculture. Leary borrowed the phrase from the Canadian media guru, Marshall McLuhan.
Regrettably, after psychedelics became “recreational drugs,” they were made illegal. That’s when serious investigation into the medicinal applications of that family of drugs stopped.
One of those early studies in the 1950s was at the Saskatchewan Mental Hospital in Weyburn. That’s when the term “psychedelic” was first coined.
Saskatchewan was home to some of the most important psychedelic research in the world at the time. Treating patients with a single dose of psychedelic was seen as an attractive, cost-effective approach.
It fit with the goals of a new, publicly funded health-care system started by Saskatchewan’s new premier, Tommy Douglas. The treatment was aimed at restoring health and autonomy to patients who had long been confined to asylums.
Since then, the prohibition of drugs has been a disaster. Instead of limiting drug use, making them illegal under the criminal code has increased the use of unregulated, contaminated and dangerous street drugs. This is especially true of synthetic opioids such as Fentanyl.
The trouble with opioids is that they are addictive with ever-increasing doses.
Now that the hippy era is just a nostalgic memory and acid trips are no longer in vogue, the medical uses of psychedelics are being investigated again.
Health Canada has only approved psilocybin treatment for people in palliative care. The Vancouver Island based company, Numinus Wellness, is one of many who are looking to go beyond that to the treatment of mental illness, addiction and trauma. Dr. Evan Wood, chief medical officer at Numinus says:
“With one in five Canadians currently grappling with debilitating mental-health conditions, we can’t afford not to look at psilocybin seriously (Globe and Mail, Sept. 4, 2021).”
The pandemic has further increased the incidence of mental illness.
The difference between using opioids versus psychedelics is that one or two treatments of psychedelics can completely change your view of reality.
“A session with psilocybin seems to disrupt this network,” adds Wood, “reset it and decrease its activity, thus alleviating the symptoms. The changes it appears to be bringing about with people are really profound.
“It gets at the root of what’s driving people to these mental disorders. Instead of giving them chemicals that numb those feelings, these treatments help you put that trauma behind you.”
David Charbonneau is a retired TRU electronics instructor who hosts a blog at http://www.eyeviewkamloops.wordpress.com.